Active targeted Janus nanoparticles enable anti-angiogenic drug combining chemotherapy agent to prevent postoperative hepatocellular carcinoma recurrence

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2021) Hyuna Sung et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Platelet-Membrane-Coated Nanoparticles Enable Vascular Disrupting Agent Combining Anti-Angiogenic Drug for Improved Tumor Vessel Impairment

(2021) Bozhao Li et al.   NANO LETTERS

Phase 2 Study of Adjuvant Radiotherapy Following Narrow‐Margin Hepatectomy in Patients With HCC

(2021) Bo Chen et al.   HEPATOLOGY

Combination of tumour-infarction therapy and chemotherapy via the co-delivery of doxorubicin and thrombin encapsulated in tumour-targeted nanoparticles

(2020) Suping Li et al.   Nature Biomedical Engineering

Advances in drug delivery for post-surgical cancer treatment

(2019) Lin-Lin Bu et al.   BIOMATERIALS

Postoperative adjuvant sorafenib improves survival outcomes in hepatocellular carcinoma patients with microvascular invasion after R0 liver resection: a propensity score matching analysis

(2019) Xiu-Ping Zhang et al.   HPB

Significance of the surgical hepatic resection margin in patients with a single hepatocellular carcinoma

(2019) T. Aoki et al.   BRITISH JOURNAL OF SURGERY

Low density lipoprotein receptor (LDLR)-targeted lipid nanoparticles for the delivery of sorafenib and Dihydroartemisinin in liver cancers

(2019) Zhengfeng Wang et al.   LIFE SCIENCES

Polylactide-tethered prodrugs in polymeric nanoparticles as reliable nanomedicines for the efficient eradication of patient-derived hepatocellular carcinoma

(2018) Hangxiang Wang et al.   Theranostics

Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma

(2018) Xin-Fei Xu et al.   JAMA Surgery

Synergistic chemotherapeutic effect of sorafenib-loaded pullulan-Dox conjugate nanoparticles against murine breast carcinoma

(2017) Junhui Sui et al.   Nanoscale

In situ activation of platelets with checkpoint inhibitors for post-surgical cancer immunotherapy

(2017) Chao Wang et al.   Nature Biomedical Engineering

Carrier-Free, Chemophotodynamic Dual Nanodrugs via Self-Assembly for Synergistic Antitumor Therapy

(2016) Ruiyun Zhang et al.   ACS Applied Materials & Interfaces

A Review and Update of Treatment Options and Controversies in the Management of Hepatocellular Carcinoma

(2016) Mashaal Dhir et al.   ANNALS OF SURGERY

Multifunctional all-in-one drug delivery systems for tumor targeting and sequential release of three different anti-tumor drugs

(2016) Li Fan et al.   BIOMATERIALS

Multilayer-Coated Liquid Crystalline Nanoparticles for Effective Sorafenib Delivery to Hepatocellular Carcinoma

(2015) Raj Kumar Thapa et al.   ACS Applied Materials & Interfaces

Multifunctional Bismuth Selenide Nanocomposites for Antitumor Thermo-Chemotherapy and Imaging

(2015) Zhenglin Li et al.   ACS Nano

Iron Oxide @ Polypyrrole Nanoparticles as a Multifunctional Drug Carrier for Remotely Controlled Cancer Therapy with Synergistic Antitumor Effect

(2013) Chao Wang et al.   ACS Nano

Near-Infrared Light-Triggered, Targeted Drug Delivery to Cancer Cells by Aptamer Gated Nanovehicles

(2012) Xinjian Yang et al.   ADVANCED MATERIALS

Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles

(2011) Hai Wang et al.   BIOMATERIALS

Doxorubicin Plus Sorafenib vs Doxorubicin Alone in Patients With Advanced Hepatocellular Carcinoma

(2010) Ghassan K. Abou-Alfa et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION